acarix

Press

August 6, 2024

09 May 2023

Acarix och American College of Cardiology samarbetar gällande första versionens kliniska protokoll för CADScor System

New York och Washington (9 maj 2023) -- Acarix, ledande inom akustisk och AI-baserad hjärtdiagnostik, tillkännager idag, i samarbete me...

Continue reading

acarix

Press

August 6, 2024

09 May 2023

Acarix and the American College of Cardiology collaborate on first edition framework for CADScor System

New York and Washington (May 9, 2023) -- Acarix, a leader in acoustic and AI-based cardiac diagnostics, announced today, in collaborati...

Continue reading

acarix

News

August 6, 2024

09 May 2023

Acarix and the American College of Cardiology collaborate on first edition framework for CADScor System

Acarix, a leader in acoustic and AI-based cardiac diagnostics, announced today, in collaboration with the American College of Cardiolog...

Continue reading

acarix

News

August 6, 2024

04 May 2023

Acarix to present at Redeye Investor Forum

Acarix to Present at the Redeye Investor Forum. A live broadcast where different companies, including Acarix, will show a 12-minute pre...

Continue reading

acarix

Press

August 6, 2024

03 May 2023

Helen Ljungdahl Round, Acarix VD & koncernchef presenterar på Redeye Investor Forum

Den 4 maj kl 14.40 presenterar Helen Ljungdahl Round, Acarix VD & koncernchef, den senaste utvecklingen i bolaget på Redeye Investo...

Continue reading

acarix

Press

August 6, 2024

03 May 2023

Helen Ljungdahl Round, Acarix President & CEO presents at Redeye Investor Forum

On May 4th at 14.40 Helen Ljungdahl Round, Acarix President & CEO, presents the latest developments in the company at the Redeye In...

Continue reading

acarix

Press

August 6, 2024

02 May 2023

Acarix presenterar på Aktiespararnas Aktiedag 2023 i Stockholm

Acarix, ledande inom akustisk och AI-baserad hjärtdiagnostik, meddelar att bolaget kommer att presentera på Aktiespararnas Aktiedag 202...

Continue reading

acarix

Press

August 6, 2024

02 May 2023

Acarix to present at the 2023 Aktiespararna Share Day in Stockholm

Acarix, a leader in acoustic and AI-based cardiac diagnostics, announces that the company will present at the 2023 Aktiespararna Share ...

Continue reading

acarix

Press

August 6, 2024

02 May 2023

Idag inleds nyttjandeperioden för Acarix teckningsoptioner av serie 2022:U

Acarix AB (publ) (“Acarix” eller “Bolaget”) genomförde under december 2022 en företrädesemission av aktier och teckningsoptioner av ser...

Continue reading

acarix

Press

August 6, 2024

02 May 2023

The exercise period for Acarix warrants of series 2022:U begins today

In December 2022, Acarix AB (publ) (“Acarix” or the “Company”) carried out a rights issue of shares and warrants of series 2022:U (the ...

Continue reading

acarix

News

August 6, 2024

02 May 2023

The exercise period for Acarix warrants of series 2022:U begins today

In December 2022, Acarix AB (publ) (“Acarix” or the “Company”) carried out a rights issue of shares and warrants of series 2022:U (the ...

Continue reading

acarix

News

August 6, 2024

02 May 2023

Acarix to present at the 2023 Aktiespararna Share Day in Stockholm

Acarix will present at the 2023 Aktiespararna Share Day in Stockholm on May 3, 2023Nine CEOs, including Acarix CEO Helen Ljungdahl Roun...

Continue reading